Navigation Links
Combination therapy leads to partial recovery from spinal cord injury in rats

riments also used a combination of outcomes -- physiology, behavior, and anatomy -- to point clearly at myelination as the cause for improved function," says Naomi Kleitman, Ph.D., the NINDS program director for the grants that funded this work. "The study also is a good example of strong collaboration between two spinal cord injury research centers, one at the University of Louisville and the other at the University of Miami in Florida."

The researchers are now investigating ways to improve this type of therapy with additional genetic modifications to the transplanted cells, and they plan to test similar techniques that start with undifferentiated embryonic stem (ES) cells instead of glial-restricted precursor cells. ES cells would be better for human studies than glial-restricted precursors because ES cells can be more readily obtained, Dr. Whittemore says.

[1]Cao Q, Xu X-M, DeVries WH, Enzmann GU, Ping P, Tsoulfas P, Wood PM, Bunge MB, Whittemore SR. "Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells." Journal of Neuroscience, July 27, 2005, Vol. 25, No. 30, pp. 6947-6957.


'"/>

Source:NIH


Page: 1 2 3

Related biology news :

1. Combination therapy boosts effectiveness of telomere-directed cancer cell death
2. Combination therapy improves AIDS-related lymphoma outcome
3. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
4. Combination therapy shows promising results in patients with advanced lung cancer
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Gene therapy converts dead bone graft to new, living tissue
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. New therapy for HIV/AIDS eliminates needles and excessive toxicity
Post Your Comments:
Breaking Biology News(10 mins):New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2Olympus Managed Health Care Nominated for Prestigious International Award 57106 1Olympus Managed Health Care Nominated for Prestigious International Award 57106 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 1American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 1Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 2Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 4Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 5
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3